世界の医薬品市場は、2023年に約1兆5,508億4000万米ドルと評価され、2024年から2032年の予測期間にわたって6.12%のCAGRで拡大すると予想されています。バイオテクノロジーの急速な進歩、医薬品開発への投資の増加、慢性疾患の蔓延の増加に後押しされ、医薬品業界は前例のないペースで進化しています。革新的な治療法、個別化医療、生物製剤の需要は、医薬品研究の限界を押し広げ続け、治療オプションの大きな進歩につながっています。さらに、創薬における人工知能（AI）と機械学習の統合により、新しい治療法の開発が加速し、市場投入までの時間が短縮され、標的療法の精度が向上しています。
高齢化と生活習慣病の負担増大による医療費の急増は、市場拡大の肥沃な土壌を生み出しました。政府と民間企業は、精密医療、希少疾患治療、バイオシミラーに重点を置き、研究開発に多額の投資を行っています。規制遵守への重点が高まり、革新的な医薬品の承認プロセスが合理化されていることから、医薬品の発売が加速しています。しかし、厳格な規制、医薬品開発コストの高さ、医療保険者と政府機関からの価格圧力の高まりは、市場の成長にとって大きな課題となっています。
北アメリカの医薬品市場は、強力な研究開発インフラ、確立された医療制度、革新を促進する強力な規制枠組みに支えられ、引き続き優位に立っています。アメリカは、バイオテクノロジー、遺伝子治療、免疫療法への多額の投資に支えられ、引き続き主要な収益源となっています。医療費の増加と希少疾患治療への注目の高まりに後押しされ、ヨーロッパは世界の医薬品市場で大きなシェアを占めています。一方、アジア太平洋地域は、医療へのアクセスの拡大、政府の好ましい政策、中国、インド、日本における医薬品製造能力の向上に牽引され、最も急成長している市場として浮上しています。
世界のヘルスケアのトレンドがパーソナライズ医療とバイオ医薬品のイノベーションへと移行する中、製薬大手は市場での足場を強化するために、合併、買収、戦略的提携に積極的に取り組んでいます。mRNAベースの治療法、遺伝子編集、細胞療法などの新興技術は、治療パラダイムを再定義し、業界のプレーヤーに有望な機会を提供しています。製薬業界が進化し続ける中、企業は競争の激しい環境で優位に立つために、俊敏性、イノベーション、デジタル変革を優先しています。
目次
Table of Contents
Chapter 1.Global Pharmaceutical Market Executive Summary
1.1.Global Pharmaceutical Market Size & Forecast (2022-2032)
1.2.Regional Summary
1.3.Segmental Summary
1.3.1.By Molecule Type
1.3.2.By Product
1.3.3.By Type
1.3.4.By Disease
1.3.5.By Age Group
1.3.6.By Route of Administration
1.3.7.By Distribution Channel
1.4.Key Trends
1.5.Recession Impact
1.6.Analyst Recommendation & Conclusion
Chapter 2.Global Pharmaceutical Market Definition and Research Assumptions
2.1.Research Objective
2.2.Market Definition
2.3.Research Assumptions
2.3.1.Inclusion & Exclusion
2.3.2.Limitations
2.3.3.Supply Side Analysis
2.3.3.1.Availability
2.3.3.2.Infrastructure
2.3.3.3.Regulatory Environment
2.3.3.4.Market Competition
2.3.3.5.Economic Viability (Consumer’s Perspective)
2.3.4.Demand Side Analysis
2.3.4.1.Regulatory Frameworks
2.3.4.2.Technological Advancements
2.3.4.3.Environmental Considerations
2.3.4.4.Consumer Awareness & Acceptance
2.4.Estimation Methodology
2.5.Years Considered for the Study
2.6.Currency Conversion Rates
Chapter 3.Global Pharmaceutical Market Dynamics
3.1.Market Drivers
3.1.1.Rapid Technological Advancements and R&D Investments
3.1.2.Increasing Prevalence of Chronic Diseases
3.1.3.Growing Demand for Personalized and Targeted Therapies
3.2.Market Challenges
3.2.1.High Drug Development and Manufacturing Costs
3.2.2.Stringent Regulatory Requirements and Pricing Pressures
3.3.Market Opportunities
3.3.1.Innovations in Biologics and Biosimilars
3.3.2.Expansion into Emerging Markets
3.3.3.Advancements in AI-Driven Drug Discovery
Chapter 4.Global Pharmaceutical Market Industry Analysis
4.1.Porter’s 5 Force Model
4.1.1.Bargaining Power of Suppliers
4.1.2.Bargaining Power of Buyers
4.1.3.Threat of New Entrants
4.1.4.Threat of Substitutes
4.1.5.Competitive Rivalry
4.1.6.Futuristic Approach to Porter’s 5 Force Model
4.1.7.Porter’s 5 Force Impact Analysis
4.2.PESTEL Analysis
4.2.1.Political
4.2.2.Economical
4.2.3.Social
4.2.4.Technological
4.2.5.Environmental
4.2.6.Legal
4.3.Top Investment Opportunity
4.4.Top Winning Strategies
4.5.Disruptive Trends
4.6.Industry Expert Perspective
4.7.Analyst Recommendation & Conclusion
Chapter 5.Global Pharmaceutical Market Size & Forecasts by Molecule Type 2022-2032
5.1.Segment Dashboard
5.2.Global Pharmaceutical Market: Molecule Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1.Small Molecules
5.2.2.Biologics
Chapter 6.Global Pharmaceutical Market Size & Forecasts by Product 2022-2032
6.1.Segment Dashboard
6.2.Global Pharmaceutical Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1.Prescription Drugs
6.2.2.Over-the-Counter (OTC) Drugs
Chapter 7.Global Pharmaceutical Market Size & Forecasts by Type 2022-2032
7.1.Segment Dashboard
7.2.Global Pharmaceutical Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1.Branded Drugs
7.2.2.Generic Drugs
Chapter 8.Global Pharmaceutical Market Size & Forecasts by Disease 2022-2032
8.1.Segment Dashboard
8.2.Global Pharmaceutical Market: Disease Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1.Cardiovascular Diseases
8.2.2.Oncology
8.2.3.Neurological Disorders
8.2.4.Infectious Diseases
8.2.5.Diabetes
8.2.6.Respiratory Diseases
8.2.7.Others
Chapter 9.Global Pharmaceutical Market Size & Forecasts by Age Group 2022-2032
9.1.Segment Dashboard
9.2.Global Pharmaceutical Market: Age Group Revenue Trend Analysis, 2022 & 2032 (USD Billion)
9.2.1.Pediatric
9.2.2.Adults
9.2.3.Geriatric
Chapter 10.Global Pharmaceutical Market Size & Forecasts by Route of Administration 2022-2032
10.1.Segment Dashboard
10.2.Global Pharmaceutical Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
10.2.1.Oral
10.2.2.Injectable
10.2.3.Topical
10.2.4.Others
Chapter 11.Global Pharmaceutical Market Size & Forecasts by Distribution Channel 2022-2032
11.1.Segment Dashboard
11.2.Global Pharmaceutical Market: Distribution Channel Revenue Trend Analysis, 2022 & 2032 (USD Billion)
11.2.1.Retail Pharmacies
11.2.2.Hospital Pharmacies
11.2.3.Online Pharmacies
Chapter 12.Global Pharmaceutical Market Size & Forecasts by Region 2022-2032
12.1.North America Pharmaceutical Market
12.1.1.U.S. Pharmaceutical Market
12.1.1.1.Molecule Type Breakdown Size & Forecasts, 2022-2032
12.1.1.2.Product Breakdown Size & Forecasts, 2022-2032
12.1.2.Canada Pharmaceutical Market
12.2.Europe Pharmaceutical Market
12.2.1.U.K. Pharmaceutical Market
12.2.2.Germany Pharmaceutical Market
12.2.3.France Pharmaceutical Market
12.2.4.Spain Pharmaceutical Market
12.2.5.Italy Pharmaceutical Market
12.2.6.Rest of Europe Pharmaceutical Market
12.3.Asia-Pacific Pharmaceutical Market
12.3.1.China Pharmaceutical Market
12.3.2.India Pharmaceutical Market
12.3.3.Japan Pharmaceutical Market
12.3.4.Australia Pharmaceutical Market
12.3.5.South Korea Pharmaceutical Market
12.3.6.Rest of Asia-Pacific Pharmaceutical Market
12.4.Latin America Pharmaceutical Market
12.4.1.Brazil Pharmaceutical Market
12.4.2.Mexico Pharmaceutical Market
12.4.3.Rest of Latin America Pharmaceutical Market
12.5.Middle East & Africa Pharmaceutical Market
12.5.1.Saudi Arabia Pharmaceutical Market
12.5.2.South Africa Pharmaceutical Market
12.5.3.Rest of MEA Pharmaceutical Market
Chapter 13.Competitive Intelligence
13.1.Key Company SWOT Analysis
13.1.1.Pfizer Inc.
13.1.2.Johnson & Johnson
13.1.3.Novartis AG
13.2.Top Market Strategies
13.3.Company Profiles
13.3.1.Pfizer Inc.
13.3.1.1.Key Information
13.3.1.2.Overview
13.3.1.3.Financial (Subject to Data Availability)
13.3.1.4.Product Summary
13.3.1.5.Market Strategies
13.3.2.Johnson & Johnson
13.3.3.Novartis AG
13.3.4.Merck & Co., Inc.
13.3.5.Roche Holding AG
13.3.6.Sanofi S.A.
13.3.7.GlaxoSmithKline plc
13.3.8.Bristol-Myers Squibb Company
13.3.9.AbbVie Inc.
13.3.10.AstraZeneca plc
13.3.11.Eli Lilly and Company
13.3.12.Amgen Inc.
13.3.13.Bayer AG
13.3.14.Takeda Pharmaceutical Company Limited
13.3.15.Gilead Sciences, Inc.
Chapter 14.Research Process
14.1.Research Process
14.1.1.Data Mining
14.1.2.Analysis
14.1.3.Market Estimation
14.1.4.Validation
14.1.5.Publishing
14.2.Research Attributes
List of Tables
TABLE 1.Global Pharmaceutical Market, Report Scope
TABLE 2.Global Pharmaceutical Market Estimates & Forecasts by Region 2022-2032 (USD Billion)
TABLE 3.Global Pharmaceutical Market Estimates & Forecasts by Molecule Type 2022-2032 (USD Billion)
TABLE 4.Global Pharmaceutical Market Estimates & Forecasts by Product 2022-2032 (USD Billion)
TABLE 5.Global Pharmaceutical Market Estimates & Forecasts by Type 2022-2032 (USD Billion)
TABLE 6.Global Pharmaceutical Market Estimates & Forecasts by Disease 2022-2032 (USD Billion)
TABLE 7.Global Pharmaceutical Market Estimates & Forecasts by Age Group 2022-2032 (USD Billion)
TABLE 8.Global Pharmaceutical Market Estimates & Forecasts by Route of Administration 2022-2032 (USD Billion)
TABLE 9.Global Pharmaceutical Market Estimates & Forecasts by Distribution Channel 2022-2032 (USD Billion)
TABLE 10.Global Pharmaceutical Market by Region, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 11.U.S. Pharmaceutical Market Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 12.U.S. Pharmaceutical Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
TABLE 13.Canada Pharmaceutical Market Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 14.Canada Pharmaceutical Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
…
(This list is not complete; the final report does contain more than 100 tables. The list may be updated in the final deliverable.)
List of Figures
FIG 1.Global Pharmaceutical Market, Research Methodology
FIG 2.Global Pharmaceutical Market, Market Estimation Techniques
FIG 3.Global Market Size Estimates & Forecast Methods.
FIG 4.Global Pharmaceutical Market, Key Trends 2023
FIG 5.Global Pharmaceutical Market, Growth Prospects 2022-2032
FIG 6.Global Pharmaceutical Market, Porter’s 5 Force Model
FIG 7.Global Pharmaceutical Market, PESTEL Analysis
FIG 8.Global Pharmaceutical Market, Value Chain Analysis
FIG 9.Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIG 10.Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIG 11.Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIG 12.Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIG 13.Global Pharmaceutical Market by Segment, 2022 & 2032 (USD Billion)
FIG 14.Global Pharmaceutical Market, Regional Snapshot 2022 & 2032
FIG 15.North America Pharmaceutical Market 2022 & 2032 (USD Billion)
FIG 16.Europe Pharmaceutical Market 2022 & 2032 (USD Billion)
FIG 17.Asia-Pacific Pharmaceutical Market 2022 & 2032 (USD Billion)
FIG 18.Latin America Pharmaceutical Market 2022 & 2032 (USD Billion)
FIG 19.Middle East & Africa Pharmaceutical Market 2022 & 2032 (USD Billion)
FIG 20.Global Pharmaceutical Market, Company Market Share Analysis (2023)
…
(This list is not complete; the final report does contain more than 50 figures. The list may be updated in the final deliverable.)
